Eurozone - Spark Newswire

1 minute read

European Medicines Agency Accepted Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease

Today, 2:32 AM

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril antibody[1], for the treatment of Early Alzheimer's disease (mild cognitive impairment due to Alzheimer's disease (AD)

BIIB

3 minute read

Dow Surges Over 100 Points; World Acceptance Shares Spike Higher

By Lisa Levin

Today, 2:32 AM

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.35% to 33,863.38 while the NASDAQ rose 1.33% to 11,463.77. The S&P 500 also rose, gaining, 0.75% to 4,046.34.

ARDS

3 minute read

US GDP Rises 2.9% In Q4; Crude Oil Up Over 1%

By Lisa Levin

Today, 2:32 AM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.27% to 33,834.44 while the NASDAQ rose 0.97% to 11,422.61. The S&P 500 also rose, gaining, 0.58% to 4,039.46.

ARDS

1 minute read

Bloomberg Reported Wednesday FTC Filed Microsoft-Activision Suit To Head Off EU Settlement

By Charles Gross

Today, 2:32 AM

https://www.bloomberg.com/news/articles/2023-01-25/lina-khan-s-ftc-sued-microsoft-over-activision-deal-to-head-off-eu-settlement?utm_source=google&utm_medium=bd&cmpId=google

ATVI

3 minute read

AstraZeneca Announced Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer

By Charles Gross

Today, 2:32 AM

AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.

AZN

3 minute read

Nasdaq Falls 50 Points; eHealth Shares Spike Higher

By Lisa Levin

Today, 2:32 AM

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18. The S&P 500 also fell, dropping, 0.22% to 4,008.11.

ALTI

3 minute read

Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings

By Lisa Levin

Today, 2:32 AM

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96. The S&P 500 also fell, dropping, 1.38% to 3,961.34.

EHTH

1 minute read

Germany To Give Ukraine 14 Modern Leopard 2-A6 Tanks

By Charles Gross

Today, 2:32 AM

-Wall Street Journal Citing Government Spokesman

EWG

1 minute read

XPENG Tweets: We’re launching our two new EVs in Europe on February 3, 2023

By Charles Gross

Today, 2:32 AM

https://twitter.com/XPengMotors/status/1618197822255558656

XPEV

3 minute read

Dow Rises 80 Points; Altamira Therapeutics Shares Plunge

By Lisa Levin

Today, 2:32 AM

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500 also fell, dropping, 0.11% to 4,015.51.

AXLA